Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-24-131838
Filing Date
2024-11-29
Accepted
2024-11-29 14:30:08
Documents
12
Period of Report
2024-11-22
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A drrx-20241122.htm   iXBRL 8-K/A 49609
2 EX-99.1 drrx-ex99_1.htm EX-99.1 390069
  Complete submission text file 0000950170-24-131838.txt   577972

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT drrx-20241122.xsd EX-101.SCH 30439
14 EXTRACTED XBRL INSTANCE DOCUMENT drrx-20241122_htm.xml XML 4894
Mailing Address 10240 BUBB ROAD CUPERTINO CA 95014
Business Address 10240 BUBB ROAD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

EIN.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-31615 | Film No.: 241515953
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)